Navigation Links
Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent
Date:9/18/2009

NATICK, Mass., Sept. 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of patient enrollment in the workhorse portion of its PLATINUM clinical program. PLATINUM is a global, randomized, pivotal controlled trial designed to support U.S. Food and Drug Administration (FDA) and Japanese Ministry of Health, Labor and Welfare (MHLW) approval of the platinum chromium PROMUS((R)) Element(TM) Everolimus-Eluting Coronary Stent System. The trial enrolled 1,532 patients with up to two de novo lesions at more than 140 sites worldwide, and completed enrollment two months ahead of schedule.

The PLATINUM workhorse trial evaluates the new PROMUS Element Everolimus-Eluting Coronary Stent in comparison with the current PROMUS Stent, which uses the same drug dose and polymer on an earlier cobalt chromium alloy stent design. Two parallel sub-trials will evaluate the PROMUS Element Stent in small vessels and long lesions. In addition to the PROMUS Element Everolimus-Eluting Stent, the Company is developing additional variations of a bare-metal and paclitaxel-eluting stent on the Element platform. The pivotal PERSEUS clinical trial compares the TAXUS((R)) Element(TM) Stent to the TAXUS Express2(TM) Stent. The PERSEUS trial completed enrollment in October 2008, and the primary endpoint will be reported at the ACC conference in 2010.

"The brisk enrollment in the PLATINUM trial reflects the strong interest in this new platinum chromium stent platform," said Gregg W. Stone, M.D., Professor of Medicine and the Director of Research and Education at the Center for Interventional Vascular Therapy at the Columbia University Medical Center/New York-Presbyterian Hospital and Principal Investigator of the trial.

The Element Stent platfo
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Boston Scientifics Urology/Gynecology Business Forms Marketing Alliance with Bladder Health Network
2. Boston Scientific Statement on the Passing of Senator Edward Kennedy
3. Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT-CRT Trial
4. Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology
5. Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System
6. Boston Scientific to Participate in Wachovia Conference
7. Boston Scientifics SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)
8. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
9. FDA Approves Boston Scientifics Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
10. Angiotechs corporate partner, Boston Scientific, announces launch of third-generation TAXUS(R) Element(TM) Stent
11. Boston Scientific Welcomes Launch of Syntax Score Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... ON , July 11, 2014 /CNW/ - Sunovion ... approved APTIOM TM (eslicarbazepine acetate) for use as ... seizures in patients with epilepsy who are not satisfactorily ... indicated for use in patients under 18 years of ... most common neurological disorders and according to Epilepsy Canada, ...
(Date:7/10/2014)... 10, 2014 Deep Knowledge Ventures ... Forum on ‘Commercialising Longevity Research’ and welcomed a ... the London Bioscience Innovation Center for the event, ... Aging Analytics Ltd. The meeting highlighted the need ... research for age-related disease, as well as the ...
(Date:7/10/2014)... 2014 OMICS Group’s 5th International conference ... August, 2014 at Double Tree by Hilton Beijing, China ... in Analytical & Bioanalytical research methods only to facilitate ... this occasion, Dr. Srinubabu Gedela, MD of OMICS Group ... a remarkable one in bringing a unique and international ...
(Date:7/10/2014)... Capital, a firm specializing in acquiring and managing food ... the Slim-Fast brand from Unilever. Unilever will retain a ... were not disclosed. Slim-Fast is a branded ... shakes, powders, bars and snacks to retail customers throughout ... United Kingdom and Ireland.  The ...
Breaking Biology Technology:Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Kainos Capital Acquires Slim-Fast From Unilever 2
... 15, 2011 Reportlinker.com announces that a ... its catalogue: India Biotechnology ... http://www.reportlinker.com/p0553099/India-Biotechnology-in-India-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc This report analyzes ... US$ million by the following Key Sectors ...
... NEW BRUNSWICK, N.J., June 14, 2011 Psoriasis is ... of the world,s population or more than 125 million ... others, it is disabling. On a continuing ... an article published in the Journal of Investigative ...
... Inc. , a California-based clean technology company serving the ... yeast technology from the USDA Forest Products Laboratory (FPL) ... the fermentation of C5 sugars, such as xylose, to ... Cooperative Research and Development Agreement (CRADA) between FPL and ...
Cached Biology Technology:Reportlinker Adds India Biotechnology in India Industry 2Reportlinker Adds India Biotechnology in India Industry 3Reportlinker Adds India Biotechnology in India Industry 4Reportlinker Adds India Biotechnology in India Industry 5Reportlinker Adds India Biotechnology in India Industry 6Reportlinker Adds India Biotechnology in India Industry 7Reportlinker Adds India Biotechnology in India Industry 8Reportlinker Adds India Biotechnology in India Industry 9Reportlinker Adds India Biotechnology in India Industry 10Reportlinker Adds India Biotechnology in India Industry 11Reportlinker Adds India Biotechnology in India Industry 12Actinobac Biomed, Inc. Demonstrates In Vivo Efficacy for Psoriasis Treatment 2EdeniQ Licenses Yeast Technology from USDA 2
(Date:7/11/2014)... from the Max Planck Institute for Medical Research in ... understanding photosynthesis, the process by which the Earth first ... and which is therefore crucial for all higher forms ... the first direct visualization of a crucial event in ... specific protein complex, photosystem II, splits water into hydrogen ...
(Date:7/11/2014)... marginal division of the striatum is also involved ... degree of substance P in the striatal marginal ... and his team, College of Biophotonics, South China ... substance P receptor, neurokinin 1 was highly expressed ... normal rats. Unilateral or bilateral injection of an ...
(Date:7/11/2014)... Rio de Janeiro, Brazil- In the brains of ... mechanism that allows an electric or chemical signal ... another. Chemical synapses, which are the most abundant ... inhibitory. Synapse formation is crucial for learning, memory, ... and inhibitory synapses critical for brain function. ...
Breaking Biology News(10 mins):A first direct glimpse of photosynthesis in action 2Blame it on the astrocytes 2
... French . Researchers at the Montreal ... basis of depression in male athletes with persisting post-concussion ... Archives of General Psychiatry, has important clinical implications for ... concussion. Depression is one of a number ...
... release is also available in German . ... modified bacteria produce human insulin. In future, gene therapy should ... a diseased organism so that they can address deficiencies to ... to work, foreign (or synthetic) DNA must be introduced into ...
... the interaction of genes and environment in the ... King,s College London, has been awarded the Mortimer ... Developmental Psychobiology. Presented jointly by the Sackler Institute ... and the Sackler Institute for Developmental Psychobiology at ...
Cached Biology News:MNI researchers locate neurological basis of depression following sports concussion 2Cells get sprayed 2Research pioneer in the developmental origins of psychiatric illness is awarded the Sackler prize 2
MHC Volumes 1 & 2...
BD IMagnet 1 each...
Vertical Rack (five box vapor phase rack), includes 2.0" (5.1cm) boxes...
... M.W. Turner (1997). • This book ... in the production of high-quality antibodies, ... the standardisation of antibodies and antigens, ... systems, enzyme immunoassays for detecting cell-surface ...
Biology Products: